Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/18/2012CA2817197A1 Fusion proteins comprising an engineered knottin peptide and uses thereof
05/18/2012CA2817015A1 Protein complexes for antigen binding and methods of use
05/18/2012CA2817011A1 Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity
05/18/2012CA2816593A1 Methods for organ regeneration
05/18/2012CA2814814A1 Polypeptides derived from il-2 having agonist activity, for the therapy of cancer and chronic infections
05/18/2012CA2813661A1 Pharmaceutical composition, methods for treating and uses thereof
05/18/2012CA2812164A1 Buffered ophthalmic compositions and methods of use thereof
05/18/2012CA2811113A1 Skin permeating and cell entering (space) peptides and methods of use thereof
05/17/2012US20120124703 Novel coprinus comatus and tremella mesenterica mushroom strains, products and extracts thereof and compositions comprising them
05/17/2012US20120124684 Compositions and methods using alpha beta-crystallin in protecting the myocardium from ischemia/reperfusion injury
05/17/2012US20120123186 Therapeutic regimen for treating cancer
05/17/2012US20120123182 Devices for thermally induced transformations controlled by irradiation of functionalized fullerenes
05/17/2012US20120123093 Novel surface antigen
05/17/2012US20120123090 Novel tumor antigen protein sart-3 and tumor antigen peptides thereof
05/17/2012US20120122962 Modified Small Interfering RNA Molecules and Methods of Use
05/17/2012US20120122803 Alpha-conotoxin mii analogs
05/17/2012US20120122802 Animal protein-free pharmaceutical compositions
05/17/2012US20120122801 Mannose-6-phosphate receptor mediated gene transfer into muscle cells
05/17/2012US20120122800 Long-Acting DNA Dendrimers and Methods Thereof
05/17/2012US20120122799 Cyclic peptide antitumor agents
05/17/2012US20120122798 Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
05/17/2012US20120122797 Peptidic compound and use of same
05/17/2012US20120122796 Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredient
05/17/2012US20120122795 Accelerated extension of axons
05/17/2012US20120122794 Compound And Method For Treatment Of Alzheimer's Disease
05/17/2012US20120122793 S-Protected Cysteine Analogs and Related Compounds
05/17/2012US20120122792 S-t-BUTYL PROTECTED CYSTEINE DI-PEPTIDE ANALOGS AND RELATED COMPOUNDS
05/17/2012US20120122791 Substrate for cartilage cultivation using artificial collagen, and method for cartilage regeneration treatment using the substrate
05/17/2012US20120122790 Methods for the treatment of x-linked hypophosphatemia and related disorders
05/17/2012US20120122789 Methods of Reducing Myocardial Injury Following Myocardial Infarction
05/17/2012US20120122787 Methods for treating polycystic kidney disease (pkd) or other cyst forming diseases
05/17/2012US20120122786 Use of Polypeptide Micromolecule MLIF in Preparing Medicine for Preventing and Treating Myocardial Ischemia
05/17/2012US20120122785 Combination of a leucine source and an omega- 3 unsaturated fatty acid source for use in the treatment of hypercalcaemia
05/17/2012US20120122784 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
05/17/2012US20120122783 Glucagon antagonists
05/17/2012US20120122782 Complexation of metal ions with polypeptides
05/17/2012US20120122781 Peptide ligands of somatostatin receptors
05/17/2012US20120122780 Compounds, Compositions and Methods for Modulating Uric Acid Levels
05/17/2012US20120122779 Method for site-specific polyvalent display on polymers
05/17/2012US20120122778 Modified TGF-beta superfamily protein
05/17/2012US20120122777 Diagnostic agent for ischemic heart disease risk group
05/17/2012US20120122776 Dpp-iv inhibitors for treatment of diabetes in pediatric patients
05/17/2012US20120122775 Use of Ultrarapid Acting Insulin
05/17/2012US20120122774 Long-acting formulations of insulins
05/17/2012US20120122773 N-substituted-cyclic amino derivative
05/17/2012US20120122772 Agent for Suppressing Elevation of Blood GIP Concentration
05/17/2012US20120122771 STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN
05/17/2012US20120122770 Cell Cycle Arrest and Apoptosis
05/17/2012US20120122769 Antisense antibacterial compounds and methods
05/17/2012US20120122768 Alginate oligomers for use in overcoming multidrug resistance in bacteria
05/17/2012US20120122767 Lactoferrin-based biomaterials for tissue regeneration and drug delivery
05/17/2012US20120122766 Novel Polypeptide Having Angiogenesis-Inducing Activity And Antibacterial Activity, And Use Thereof For Medical Purposes
05/17/2012US20120122765 Compounds and related methods for manipulating parp-1-dependent cell death
05/17/2012US20120122764 Substituted carbamoylcycloalkyl acetic acid derivatives as nep
05/17/2012US20120122763 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors
05/17/2012US20120122762 186 Human Secreted Proteins
05/17/2012US20120122761 Methods for detecting a polymorphism in the nfkb1 gene promoter
05/17/2012US20120122760 Novel lipids for transfection of nucleic acids
05/17/2012US20120122759 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography
05/17/2012US20120122178 Human Aminoacyl-tRNA Synthetase Polypeptides Useful for the Regulation of Angiogenesis
05/17/2012US20120122111 Rna sequence-specific mediators of rna interference
05/17/2012US20120121743 Schisandra sphenanthera fruit extract and cosmetic, dermatological and nutraceutical compositions comprising same
05/17/2012US20120121725 Cosmetic composition for the treatment of acne comprising a peptide extract of schizandra
05/17/2012US20120121724 Film comprising therapeutic agents
05/17/2012US20120121720 Modulation of Beta 2 Adrenergic Receptors by Inhibitors of EGLN3 or pVHL
05/17/2012US20120121706 PAR-1 Activation by Metalloproteinase-1 (MMP-1)
05/17/2012US20120121701 Pharmaceutical composition of peptide drug and enzyme-inhibition compounds
05/17/2012US20120121684 Coating Comprising A Poly(Ethylene Glycol)-Poly(Lactide-Glycolide-Caprolactone) Interpenetrating Network
05/17/2012US20120121682 cRGD PEPTIDE DERIVATIVE AND ITS MANUFACTURE, AND IMPLANT HAVING A COATING CONTAINING A cRGD PEPTIDE DERIVATIVE
05/17/2012US20120121676 Method for manufacturing capsules, resulting capsules, and use of said capsules
05/17/2012US20120121675 Compounds which inhibit muscle contraction
05/17/2012US20120121659 Functionalized rgd peptidomimetics and their manufacture, and implant having a coating containing such functionalized rgd peptidomimetics
05/17/2012US20120121658 Functionalized rgd peptidomimetics and their manufacture, and implant having a coating containing such functionalized rgd peptidomimetics
05/17/2012US20120121656 Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
05/17/2012US20120121640 OX40/TRAIL Fusion Proteins
05/17/2012US20120121627 Peptides for active anti-cytokine immunization
05/17/2012US20120121626 Chimeric VEGF Peptides
05/17/2012US20120121624 Hepatitis c virus ns3 protease inhibitors
05/17/2012US20120121623 Novel antipathogenic peptides
05/17/2012US20120121622 Biodegradable immunomodulatory formulations and methods for use thereof
05/17/2012US20120121621 Synergistic prebiotic compositions
05/17/2012US20120121620 Anti-estrogen and immune modulator combinations for treating breast cancer
05/17/2012US20120121619 Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
05/17/2012US20120121618 Predicting And Treating Prostate Cancer
05/17/2012US20120121613 Protein conjugate having an endopeptidase- cleavable bioprotective moiety
05/17/2012US20120121612 Fermented wheat germ proteins (fwgp) for the treatment of cancer
05/17/2012US20120121602 Novel proteins
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121593 Method for determining predisposition to pulmonary infection
05/17/2012US20120121591 SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
05/17/2012US20120121590 Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein (gal-3bp, btbd17b, mac-2 binding protein)
05/17/2012US20120121589 Modified egfr ectodomain
05/17/2012US20120121588 Modulation of pilr receptors to treat sepsis
05/17/2012US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/17/2012US20120121582 Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related Disease
05/17/2012US20120121580 Methods for producing high concentration lyophilized pharmaceutical formulations
05/17/2012US20120121575 Prohibitin as target for cancer therapy
05/17/2012US20120121573 Treatment of Pulmonary Vascular Remodeling With Neprilysin
05/17/2012US20120121572 New medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity
05/17/2012US20120121571 Lysosomal Phospholipase A2 (LPLA2) Activity as a Diagnostic and Therapeutic Target for Identifying and treating Systemic Lupus Erythematosis
1 ... 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 ... 3163